263 related articles for article (PubMed ID: 32916523)
21. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies in Japanese patients with ocular myasthenia gravis.
Nagaishi A; Narita T; Woodhall M; Jacobson L; Waters P; Irani SR; Vincent A; Matsuo H
Muscle Nerve; 2021 Feb; 63(2):262-267. PubMed ID: 33094484
[TBL] [Abstract][Full Text] [Related]
23. Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.
Cenacchi G; Papa V; Fanin M; Pegoraro E; Angelini C
J Neurol; 2011 May; 258(5):746-52. PubMed ID: 21088848
[TBL] [Abstract][Full Text] [Related]
24. A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review.
Pugliese A; Nicocia G; Messina S; Toscano A; Rodolico C
Neuromuscul Disord; 2023 Feb; 33(2):145-147. PubMed ID: 36628839
[TBL] [Abstract][Full Text] [Related]
25. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
[TBL] [Abstract][Full Text] [Related]
26. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
Huda S; Woodhall MR; Vincent A; Heckmann JM
Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
[TBL] [Abstract][Full Text] [Related]
27. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
Koneczny I; Cossins J; Vincent A
J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
29. Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.
Stein B; Bird SJ
J Clin Neuromuscul Dis; 2011 Mar; 12(3):163-4. PubMed ID: 21321497
[No Abstract] [Full Text] [Related]
30. Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
Yilmaz V; Oflazer P; Aysal F; Durmus H; Poulas K; Yentur SP; Gulsen-Parman Y; Tzartos S; Marx A; Tuzun E; Deymeer F; Saruhan-Direskeneli G
PLoS One; 2015; 10(4):e0123546. PubMed ID: 25893403
[TBL] [Abstract][Full Text] [Related]
31. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
[TBL] [Abstract][Full Text] [Related]
32. Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR.
Martignago S; Fanin M; Albertini E; Pegoraro E; Angelini C
Neuropathol Appl Neurobiol; 2009 Feb; 35(1):103-10. PubMed ID: 19187062
[TBL] [Abstract][Full Text] [Related]
33. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
Yamada C; Teener JW; Davenport RD; Cooling L
J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies to agrin in myasthenia gravis patients.
Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L
PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822
[TBL] [Abstract][Full Text] [Related]
35. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.
Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W
Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283
[TBL] [Abstract][Full Text] [Related]
36. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
Jordan B; Schilling S; Zierz S
J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
[No Abstract] [Full Text] [Related]
37. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
[TBL] [Abstract][Full Text] [Related]
38. MuSK-antibody-positive myasthenia gravis in a South Asian population.
Chang T; Gunaratne P; Gamage R; Riffsy MT; Vincent A
J Neurol Sci; 2009 Sep; 284(1-2):33-5. PubMed ID: 19394052
[TBL] [Abstract][Full Text] [Related]
39. Overcoming challenges in the diagnosis and treatment of myasthenia gravis.
Evoli A; Iorio R; Bartoccioni E
Expert Rev Clin Immunol; 2016; 12(2):157-68. PubMed ID: 26675896
[TBL] [Abstract][Full Text] [Related]
40. MuSK-Ab positive myasthenia: not always grave.
Zouvelou V; Stamboulis E; Skriapa L; Tzartos SJ
J Neurol Sci; 2013 Aug; 331(1-2):150-1. PubMed ID: 23706725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
